Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

WAVE Life Sciences Ltd

WVE ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Small Cap Analyst: BUY

Last Close

$5.41

▲ +4.04%

Market Cap $1.07B · Vol 936.38K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.07B

Small Cap

Div Yield

N/A

EPS Growth

+7.29%

YoY

RSI (14)

40.34

Momentum

Beta

-1.29

vs Market

52W High

$21.72

75.09% below

52W Low

$5.01

7.98% above

Volume

936.38K

Avg 913.25K

P/B

6.15

Price-to-book

ROE

-56.16%

Return on equity

Free Float

84.49%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, WAVE Life Sciences Ltd (WVE) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does WVE pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-11.31%

-11.75%

-21.59%

-57.33%

YTD

-68.18%

-39.28%

+22.40%

-15.60%

Financials & Valuation

TTM · Annual

Total Revenue	$42.73M
Net Income	$-204,378,000.00
Revenue Growth (YoY)	-73.88%
Gross Margin	100.00%
Operating Margin	-504.09%
Net Profit Margin	-478.33%
ROE	-56.16%
ROA · ROIC	-41.26% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	67.10
P/B	6.15
P/FCF	N/A
EPS Growth	+7.29%
Outstanding Shares	197.05M

Technical Indicators

50-Day SMA	$5.87
200-Day SMA	$9.50
RSI (14)	40.34
Beta	-1.29
52-Week High	$21.72
52-Week Low	$5.01

Volume Today	936.38K
Avg Daily Volume (30D)	913.25K
Relative Volume	1.03x
Volatility (10D)	101.78
Volatility (30D)	65.70
Free Float	84.49%

Analyst Consensus

BUY

Current Price $5.41

Mean Target $19.47

52W Low$5.01 52W High$21.72

Current

Target

$5.01 $21.72

Current Analyst target

+259.90% upside potential · 17 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00B642V63

ISINSG9999014716

CountrySingapore

Sub-IndustryBio Therapeutic Drugs

Earnings DateNov 9, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company's diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease, as well as several preclinical programs utilizing the Company's broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).